Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Depreciation & Amortization (CF): 2021-2025

Historic Depreciation & Amortization (CF) for Core Scientific (CORZ) over the last 5 years, with Sep 2025 value amounting to $16.3 million.

  • Core Scientific's Depreciation & Amortization (CF) fell 43.09% to $16.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.9 million, marking a year-over-year decrease of 31.69%. This contributed to the annual value of $113.2 million for FY2024, which is 17.92% up from last year.
  • Per Core Scientific's latest filing, its Depreciation & Amortization (CF) stood at $16.3 million for Q3 2025, which was down 12.94% from $18.8 million recorded in Q2 2025.
  • Core Scientific's Depreciation & Amortization (CF)'s 5-year high stood at $68.7 million during Q4 2022, with a 5-year trough of $2.9 million in Q1 2021.
  • In the last 3 years, Core Scientific's Depreciation & Amortization (CF) had a median value of $24.2 million in 2023 and averaged $24.0 million.
  • In the last 5 years, Core Scientific's Depreciation & Amortization (CF) spiked by 1,520.65% in 2022 and then tumbled by 62.47% in 2023.
  • Core Scientific's Depreciation & Amortization (CF) (Quarterly) stood at $20.5 million in 2021, then soared by 235.59% to $68.7 million in 2022, then plummeted by 54.59% to $31.2 million in 2023, then decreased by 16.54% to $26.0 million in 2024, then crashed by 43.09% to $16.3 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $16.3 million for Q3 2025, versus $18.8 million for Q2 2025 and $19.7 million for Q1 2025.